Form 4 for CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE

Accepted 2024-06-18 00:00:00 ET · period of report 2024-06-14 · accession 0001801170-24-000129 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
M	2024-06-18	2024-06-14+	CLOV	Reynoso Jamie L.	CEO, Medicare Advantage	F - Tax	$1.09	-13.2K	2.46M	-0.5%	-$14.3K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Class A Common Stock	2024-06-15	F	D	5,378	$1.09	2,454,075	D	—	—	(F2) Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on June 15, 2024, of 6.25% of the original number of RSUs granted to the Reporting Person on on September 16, 2022, and timely reported on a Form 4 filed on September 20, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on September 15, 2026, subject to the continued service of the Reporting Person on each such vesting date.
2	Common	Class A Common Stock	2024-06-14	F	D	7,776	$1.09	2,459,453	D	—	—	(F1) Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on June 14, 2024, of 6.25% of the original number of RSUs granted to the Reporting Person on March 14, 2022, and timely reported on a Form 4 filed on March 16, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on March 14, 2026, subject to the continued service of the Reporting Person on each such vesting date.